High spectral resolution second harmonic generation microspectroscopy at thin layer interfaces with broadband continuum pulses.

We demonstrate an effective microspectroscopy technique by tracing the dispersion of second order nonlinear optical susceptibility χ (2) in single atomic layer materials. The experimental method relies on the detection of single-shot second harmonic (SH) spectra from the materials and the subsequent data normalization. The key point in our study is that we used a broadband (˜350 nm) near-infrared femtosecond continuum pulses generated at high repetition rates in a photonic crystal fiber with superior spatial quality and stable spectral power density. This is opposite to the point-by-point laser tuning method in SH generation spectroscopy that was applied extensively in the past and has shown limited precision in obtaining χ (2) dispersion. The continuum pulse technique produces spectral resolution better than 2 meV (<0.3 nm at 450 nm) and shows low (<5-6% rms) signal detection noise allowing the detection of subtle features in the χ (2) spectrum at room temperatures. Fine sub-structure features within the main peak of χ (2) spectra indicate the impact of broadened resonances due to exciton transitions in the single layer materials. • Tailored continuum pulses are used to generate second harmonic signal in non-centrosymmetric semiconductors. • SHG spectrum carries fingerprints of the bandstructure around the direct gap states. • The technique produces fine spectral resolution and much better signal-to-noise ratio compared to point-by-point wavelength tuning methods.

The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues.

Analogues of BMS-284756, a novel des-F(6)-quinolone, were synthesized and evaluated in order to determine the effects of modification of substituents on in vitro target inhibition. BMS-340281 (stereoisomer of BMS-284756), BMS-340280 (C-6 fluorinated analogue of BMS-284756), BMS-340278 (C-8-H derivative), BMS-433366 (C-8 methoxy analogue) and fluoroquinolone comparators were evaluated for antibacterial activity. The MICs of BMS-284756 were generally found to be within two-fold of the MICs of BMS-284756 analogues against a panel of Gram-positive and -negative organisms. BMS-284756 had MICs of 0.03-0.125 mg/L against Streptococcus pneumoniae strains with GyrA and ParC mutations, and was the most active quinolone. BMS-284756 and its analogues had similar activity compared with ciprofloxacin and moxifloxacin against topoisomerase IV decatenation, but were three times more active than levofloxacin. The IC(50) of BMS-284756 for human topoisomerase II (hTopo II) was 3000 times higher than its IC(50) for DNA gyrase, and no whole-cell cytotoxicity was noted. Two analogues, BMS-340280 and BMS-340278, demonstrated moderate inhibition against hTopo II and cytotoxicity in the cellular assay. BMS-284756 demonstrated greater Gram-positive antibacterial activity and similar inhibition of targets compared with other fluoroquinolones, and more favourable selectivity compared with the other BMS-284756 analogues.

CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.

The cell surface metalloproteinase CD10/neutral endopeptidase 24.11 (NEP) hydrolyzes a variety of peptide substrates and reduces cellular responses to specific peptide hormones. Because CD10/NEP modulates peptide-mediated proliferation of small cell carcinomas of the lung (SCLC) and normal fetal bronchial epithelium, we evaluated the enzyme's expression in non-small cell lung carcinomas (NSCLC). Bronchoalveolar and large cell carcinoma cell lines had low levels of CD10/NEP expression whereas squamous, adenosquamous, and adenocarcinoma cell lines had higher and more variable levels of the cell surface enzyme. Regional variations in CD10/NEP immunostaining in primary NSCLC specimens prompted us to correlate CD10/NEP expression with cell growth. In primary carcinomas of the lung, clonal NSCLC cell lines and SV40-transformed fetal airway epithelium, subsets of cells expressed primarily CD10/NEP or the proliferating cell nuclear antigen (PCNA). Cultured airway epithelial cells had the lowest levels of CD10/NEP expression when the highest percentage of cells were actively dividing; in addition, these cells grew more rapidly when cell surface CD10/NEP was inhibited. NSCLC cell lines had receptors for a variety of mitogenic peptides known to be CD10/NEP substrates, underscoring the functional significance of growth-related variability in CD10/NEP expression.